NCT02270255View on ClinicalTrials.gov

Superior Hypogastric Nerve Block for Pain Control Post-uterine Fibroid Embolization

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

November 1, 2017

Study Completion Date

November 1, 2017

Conditions
Leiomyoma
Interventions
PROCEDURE

Superior hypogastric nerve block

21g Chiba needle advanced into the superior hypogastric plexus via an anterior infraumbilical approach using the arterial catheter as a fluoroscopic landmark to target the vertebral body below.

DRUG

0.75% Ropivacaine

20 ml of 0.75% Ropivacaine

PROCEDURE

Subcutaneous injection

Injection into subcutaneous tissues in periumbilical region

DRUG

1% Xylocaine

5ml of 1% Xylocaine

Trial Locations (1)

H3A 1A1

McGill University Health Centre - Royal Victoria Hospital, Montreal

All Listed Sponsors
lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT02270255 - Superior Hypogastric Nerve Block for Pain Control Post-uterine Fibroid Embolization | Biotech Hunter | Biotech Hunter